Sakar Healthcare Limited has informed the Exchange about SAKAR, awarded by Ethiopian Pharmaceutical Supply Services in recognition of its remarkable performance and excellence in fulfilling contractual commitments during the year of 2024/25

SAKAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.7%1-day move

₹632.90

prior close

₹626.65

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.3+0.1+0.1+0.6+2.7-0.6-6.8-12.9-14.4-10.4+19.8+33.5+32.5—

Up moveDown movePending

AI summary

Sakar Healthcare has been recognized by Ethiopian Pharmaceutical Supply Services (EPSS) as one of the best suppliers for 2024-25 and received a crystal trophy. EPSS is Ethiopia's government-run pharmaceutical supply agency. The Director General of EPSS thanked Sakar for the partnership and indicated the relationship will continue with new business and refill orders. No specific contract value or order size has been disclosed in this announcement.

Likely market impact

This is a recognition/award announcement rather than a new order, so it is largely a soft positive signal on the company's export relationships. Without details on new contract value, the direct impact on revenue or stock price is limited, but it supports confidence in the company's international pharmaceutical business.